During the past decade, Meridien Research conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 19 clinical trials were completed, i.e. on average, 65.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 18 clinical trials were completed. i.e. 138.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meridien Research" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "ACADIA Pharmaceuticals Inc." with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Zevra Therapeutics" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meridien Research" #1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator, "CoLucid Pharmaceuticals" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Meridien Research" are "Adjunctive Treatment of Major Depressive Disorder" (3 trials), "Migraine" (3 trials), "Schizophrenia" (3 trials), "ADHD" (2 trials) and "Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "Meridien Research" in a lesser frequency.

Most popular intervention types in "Meridien Research" are "Drug" (28 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Lasmiditan" (3 trials), "Pimavanserin" (3 trials), "Atogepant" (2 trials) and "KP415 oral capsule" (2 trials). Other intervention names were less common.

The vast majority of trials in "Meridien Research" are 28 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Meridien Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Meridien Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Meridien Research, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".